Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Novartis launches another localised NHS eye service in UK

Will provide specialised care to people of Coventry

- PMLiVE

Catch me if you can

The rising cost of healthcare fraud

- PMLiVE

Pfizer’s Prevenar 13 price cut slammed by MSF

Global health charity says reduction of 20 cents is "negligible"

- PMLiVE

Teva’s generic Nexium wins US approval

FDA backs copy of AstraZeneca’s heartburn drug

- PMLiVE

Actavis claims top UK generics spot with Auden Mckenzie buy

Firm claims the deal will make it the UK’s third-largest pharma manufacturer

- PMLiVE

Cancer deaths in young people in UK drop by 58% in 40 years

Figures released by Cancer Research UK

- PMLiVE

Hanover wins Novo Nordisk public affairs and policy account

Will push importance of diabetes in public affairs in UK

- PMLiVE

Abraxane on course for lung cancer indication in EU

CHMP backs news indication for Celgene drug

- PMLiVE

Charity launches #SmearForSmear campaign

Jo's Cervical Cancer Trust aims to raise awareness of cancer screening

- PMLiVE

Virginia Acha leaves Amgen for ABPI

Joins UK pharma trade body as director of research, medical and innovation

Gilead Sciences

Gilead cuts hepatitis C drug prices in Germany

Discount on Sovaldi and Harvoni follows similar agreement in France

- PMLiVE

Indian generics firm GVK set to be hit with European sales ban

EU regulator raises concerns on conduct of drug studies in India

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links